Rock Springs Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-30,000
| Closed | -$558K | – | 143 |
|
|
2019
Q2 | $558K | Sell |
30,000
-320,000
| -91% | -$5.95M | 0.02% | 133 |
|
|
2019
Q1 | $8.55M | Sell |
350,000
-175,000
| -33% | -$4.28M | 0.33% | 87 |
|
|
2018
Q4 | $13.6M | Hold |
525,000
| – | – | 0.64% | 52 |
|
|
2018
Q3 | $16.6M | Hold |
525,000
| – | – | 0.6% | 59 |
|
|
2018
Q2 | $20.4M | Buy |
525,000
+49,000
| +10% | +$1.9M | 0.78% | 40 |
|
|
2018
Q1 | $13.1M | Buy |
476,000
+226,000
| +90% | +$6.24M | 0.56% | 66 |
|
|
2017
Q4 | $4.53M | Buy |
+250,000
| New | +$4.53M | 0.21% | 109 |
|
|
2015
Q2 | – | Sell |
-32,500
| Closed | -$473K | – | 120 |
|
|
2015
Q1 | $473K | Sell |
32,500
-127,500
| -80% | -$1.86M | 0.04% | 105 |
|
|
2014
Q4 | $1.61M | Buy |
160,000
+90,000
| +129% | +$906K | 0.19% | 88 |
|
|
2014
Q3 | $583K | Buy |
+70,000
| New | +$583K | 0.09% | 81 |
|